Skip to main content
IDEX Biometrics ASA logo

IDEX Biometrics ASA — Investor Relations & Filings

Ticker · IDEX ISIN · NO0013107490 LEI · 5967007LIEEXZXHECW11 OL Telecommunications, computer programming, consultancy, computing infrastructure, and other information service activities
Open in API
Filings indexed 1,321 across all filing types
Latest filing 2023-11-21 Share Issue/Capital Cha…
Country NO Norway
Listing OL IDEX

About IDEX Biometrics ASA

https://www.idexbiometrics.com/

IDEX Biometrics ASA is a technology company specializing in fingerprint identification and biometric authentication solutions. The company designs, develops, and commercializes proprietary fingerprint sensors and software for integration into smart cards. Its core products are biometric payment cards and access cards, which provide enhanced security for financial transactions and identity verification. The technology stores and matches the user's fingerprint data directly on the card, ensuring that sensitive biometric information is never stored in the cloud. This on-card approach enables secure and convenient authentication with a simple touch, replacing traditional PINs and passwords. The solutions are certified by major payment networks like Visa and Mastercard and are compliant with FIDO standards for strong online authentication, offering protection against phishing and other cyber threats for both payment and access control systems.

Recent filings

Filing Released Lang Actions
IDEX Biometrics: subscription rights exercise - 21 Nov 2023
Share Issue/Capital Change Classification · 98% confidence The document explicitly details the resolution by the board of directors to issue new ordinary shares (389,608) following the exercise of incentive subscription rights by employees. It specifies the resulting total share capital and the number of outstanding rights. This action directly relates to a change in the company's capital structure through the issuance of new shares, which aligns perfectly with the definition of 'Share Issue/Capital Change' (SHA). Although it involves employee compensation rights, the core action reported is the resulting share issuance, not the remuneration plan itself (DEF 14A) or a general financing update (CAP).
2023-11-21 English
IDEX - Disclosure of holding - 16 Nov 2023
Major Shareholding Notification Classification · 99% confidence The document is titled 'IDEX - Disclosure of holding - 16 Nov 2023' and details a change in shareholding percentage (from 96,790,756 shares to 61,512,922 shares, representing 4.4%) for a shareholder (Sundt AS) following a private placement and subsequent share lending/disposal. This directly relates to changes in significant share ownership levels, which aligns with the definition for Major Shareholding Notification (MRQ). It is not a full report, an earnings release, or a director's dealing (which focuses on executive transactions, not major shareholder changes following a capital event).
2023-11-16 English
IDEX Biometrics ASA: Private placement of NOK 35 million successfully placed 15 Nov 2023
Capital/Financing Update Classification · 98% confidence The document explicitly announces the successful placement of a private placement of new shares to raise NOK 35 million. This action involves issuing new shares as part of a financing activity to fund commercialization and development expenses. This directly aligns with the definition of 'Capital/Financing Update' (CAP), which covers company fundraising and capital structure changes. Although it involves issuing shares (which could relate to SHA), the primary focus and context is the successful completion of a capital raise/financing event.
2023-11-15 English
IDEX Biometrics ASA - Contemplated Private Placement
Capital/Financing Update Classification · 99% confidence The document is titled "IDEX Biometrics ASA - Contemplated Private Placement" and details the plan to raise capital through the issuance of new shares (Offer Shares) via a private placement, including terms for a convertible bond. This activity directly relates to fundraising, financing activities, and changes in capital structure. This aligns perfectly with the definition for Capital/Financing Update (CAP). Although it mentions an upcoming EGM, the primary focus is the financing transaction itself, not the AGM results (DVA) or the proxy materials (PSI). It is not a full annual report (10-K) or an interim report (IR), but a specific announcement about raising capital.
2023-11-15 English
IDEX Biometrics interim report for the nine months ended 30 September 2023
Investor Presentation Classification · 99% confidence The document is explicitly titled 'Third Quarter 2023 Presentation' and contains financial summaries for the 'Third Quarter 2023' and 'first nine months of 2023'. It includes slides detailing financial performance, achievements, milestones, and market outlook, which are characteristic of an investor presentation given after a quarterly earnings announcement. Since it is a presentation deck summarizing the period's results and strategy, it fits the definition of an Investor Presentation (IP). It is not the formal regulatory filing (like 10-K or IR), nor is it just the initial earnings release (ER) which is usually a press release.
2023-11-09 English
IDEX Biometrics interim report for the nine months ended 30 September 2023
Interim / Quarterly Report Classification · 100% confidence The document is titled 'Interim Report' and covers the nine-month period ended September 30, 2023. It contains substantive financial commentary, revenue growth analysis, gross profit margin data, and operating expense details, which distinguishes it from a mere announcement or certification. It provides a comprehensive overview of the company's performance, strategy, and financial status for the interim period. 9M 2023
2023-11-09 English

Browse filings by year

15 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.